How much do paid clinical trials in Fayetteville pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Are clinical trials in Fayetteville safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How do I join a study in Fayetteville, NC?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

What is the difference between a research center and a hospital study in Fayetteville?

Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

How often do new paid studies open in Fayetteville?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fayetteville.

Paid Clinical Trials Fayetteville, NC — 125 Studies Recruiting (Oct 2026)

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought

FirstHealth of the Carolinas- Speciality Center /ID# 241279 — Pinehurst, North Carolina (28.8 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT04928846)

CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms

Traumatic Brain Injury, Insomnia N/A Interventional 360 participants sought

Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi) · Sponsor: Johns Hopkins University

See eligibility & contact on ClinicalTrials.gov (NCT05663034)

Confirmatory Clinical Study in Active Ulcerative Colitis

Colitis, Ulcerative Phase 2 Interventional 204 participants sought

Cross Creek Medical Clinic — Fayetteville, North Carolina (6.0 mi) · Sponsor: MRM Health NV

See eligibility & contact on ClinicalTrials.gov (NCT07296315)

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Lupus Nephritis, Systemic Lupus Erythematosus Phase 2 Interventional 53 participants sought

Cross Creek Medical Clinic — Fayetteville, North Carolina (6.0 mi) · Sponsor: Fate Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT07570862)

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Lung Non-Small Cell Carcinoma Phase 3 Interventional 336 participants sought

FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT07388524)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought

FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05879926)

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Breast Cancer N/A Observational 1,800 participants sought

FirstHealth Outpatient Cancer Center — Pinehurst, North Carolina (28.8 mi) · Sponsor: Exact Sciences Corporation

See eligibility & contact on ClinicalTrials.gov (NCT06401421)

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Heart Failure Phase 3 Interventional 11,300 participants sought

Research Site — Fayetteville, North Carolina (6.0 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06677060)

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Heart Failure Phase 3 Interventional 4,200 participants sought

Pinehurst Medical Clinic, Inc. - East — Pinehurst, North Carolina (28.8 mi) · Sponsor: Boehringer Ingelheim

See eligibility & contact on ClinicalTrials.gov (NCT06935370)

Comparative Performance of a Vaginal Yeast Test

Vulvovaginal Candidiasis N/A Observational 1,200 participants sought

Womack Army Medical Center — Fort Bragg, North Carolina (4.1 mi) · Sponsor: Uniformed Services University of the Health Sciences

See eligibility & contact on ClinicalTrials.gov (NCT05079711)

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 710 participants sought

FirstHealth of the Carolinas, Inc. — Pinehurst, North Carolina (28.8 mi) · Sponsor: Daiichi Sankyo

See eligibility & contact on ClinicalTrials.gov (NCT07022483)

Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis

Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital Phase 3 Interventional 400 participants sought

Cross Creek Medical Clinic, PA — Fayetteville, North Carolina (6.0 mi) · Sponsor: pH-D Feminine Health LLC

See eligibility & contact on ClinicalTrials.gov (NCT07109869)

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Atrophic Vaginitis, Vaginal Atrophy N/A Interventional 2,000 participants sought

WR-Carolina Institute for Clinical Research — Fayetteville, North Carolina (6.0 mi) · Sponsor: Stratpharma AG

See eligibility & contact on ClinicalTrials.gov (NCT05953090)

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought

FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05987241)

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis Phase 3 Interventional 762 participants sought

89bio Clinical Study Site — Fayetteville, North Carolina (6.0 mi) · Sponsor: 89bio, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06419374)

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis, MASH With Fibrosis Phase 3 Interventional 1,650 participants sought

Akero Clinical Study Site — Fayetteville, North Carolina (6.0 mi) · Sponsor: Akero Therapeutics, Inc

See eligibility & contact on ClinicalTrials.gov (NCT06215716)

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

Irritable Bowel Syndrome Phase 2 Interventional 420 participants sought

GSK Investigational Site — Fayetteville, North Carolina (6.0 mi) · Sponsor: GlaxoSmithKline

See eligibility & contact on ClinicalTrials.gov (NCT07519395)

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Phase 2, Phase 3 Interventional 378 participants sought

FirstHealth of the Carolinas-Moore Regional Hospital — Pinehurst, North Carolina (28.8 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT06616584)

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ulcerative Colitis, Obesity or Overweight Phase 3 Interventional 350 participants sought

Coastal Research Institute - Fayetteville — Fayetteville, North Carolina (6.0 mi) · Sponsor: Eli Lilly and Company

See eligibility & contact on ClinicalTrials.gov (NCT06937086)

A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

MASH - Metabolic Dysfunction-Associated Steatohepatitis Phase 2 Interventional 180 participants sought

Coastal Research Institute — Fayetteville, North Carolina (6.0 mi) · Sponsor: Rivus Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07491458)

Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

Posttraumatic Headache, Mild Traumatic Brain Injury Phase 2 Interventional 404 participants sought

Womack Army Medical Center - Fort Liberty — Fort Bragg, North Carolina (4.1 mi) · Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

See eligibility & contact on ClinicalTrials.gov (NCT05049057)

ERP to Improve Functioning in Veterans With OCD

Obsessive Compulsive Disorder (OCD), Comorbid Post-Traumatic Stress Disorder and OCD N/A Interventional 160 participants sought

Fayetteville VA Medical Center, Fayetteville, NC — Fayetteville, North Carolina (6.0 mi) · Sponsor: VA Office of Research and Development

See eligibility & contact on ClinicalTrials.gov (NCT05240924)

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic Phase 3 Interventional 600 participants sought

Cross Creek Medical Clinic — Fayetteville, North Carolina (6.0 mi) · Sponsor: Janssen Research & Development, LLC

See eligibility & contact on ClinicalTrials.gov (NCT07438496)

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

Influenza, Human Phase 3 Interventional 54,000 participants sought

GSK Investigational Site — Fayetteville, North Carolina (6.0 mi) · Sponsor: GlaxoSmithKline

See eligibility & contact on ClinicalTrials.gov (NCT07805707)

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

Migraine Phase 3 Interventional 640 participants sought

Carolina Institute for Clinical Research, LLC — Fayetteville, North Carolina (6.0 mi) · Sponsor: Pfizer

See eligibility & contact on ClinicalTrials.gov (NCT05156398)

Paid Clinical Trials in Fayetteville, NC

Studies recruiting near Fayetteville right now

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms

Confirmatory Clinical Study in Active Ulcerative Colitis

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Comparative Performance of a Vaginal Yeast Test

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

ERP to Improve Functioning in Veterans With OCD

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

Studies you may be able to join near Fayetteville

See which clinical studies you may qualify for

Top-rated research centers in Fayetteville

Coastal Research Institute

Cumberland Research Associates

Clinical Counseling and Consulting Services, PLLC Assessment and Treatment Center

North Carolina Clinical Research

Superior Clinical Research, LLC

Duke Clinical Research Institute

M3 Wake Research Raleigh

Rose Research Center

UNC CTRC (Clinical & Translational Research Center)

Clinical trials in Fayetteville: what's recruiting

How to enroll in a paid study in Fayetteville

Frequently asked questions

Paid clinical trials near Fayetteville

By condition

More of NC

New paid studies open every week